Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.01
+0.01 (0.07%)
Feb 11, 2026, 1:55 PM HKT

HKG:1858 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,053805.221,2071,1991,107937.56
Other Revenue
0.640.641.042.580.910.13
1,054805.861,2091,2021,108937.69
Revenue Growth (YoY)
13.95%-33.32%0.58%8.43%18.18%9.63%
Cost of Revenue
380.78289.37353.34301.53264.11257.09
Gross Profit
672.89516.49855.18900.08844.03680.6
Selling, General & Admin
275.51285.54427.61430.31372.73272.23
Research & Development
119.89133.1157.45162.34104.8472.6
Other Operating Expenses
3.431.624.4113.339.29.45
Operating Expenses
409.69424.53593.88618.73499.58360.68
Operating Income
263.291.96261.3281.35344.44319.92
Interest Expense
-0.03-0.04-0.09-0.05--
Interest & Investment Income
23.0827.2926.4723.610.766.27
Currency Exchange Gain (Loss)
1.781.782.483.57-0.86-4.49
Other Non Operating Income (Expenses)
-0.69-0.9-0.18-4.27-4.220.18
EBT Excluding Unusual Items
287.34120.09289.99304.2350.12321.88
Impairment of Goodwill
-13.36-13.36----
Gain (Loss) on Sale of Investments
10.439.439.619.49--
Gain (Loss) on Sale of Assets
00.0400.030.01-0.19
Asset Writedown
-22.65-----
Other Unusual Items
15.4615.396.323.1617.248.16
Pretax Income
277.22131.6305.91336.88367.38329.85
Income Tax Expense
21.966.9428.0929.1645.0246.47
Earnings From Continuing Operations
255.27124.66277.82307.72322.36283.37
Minority Interest in Earnings
0.10.330.01---
Net Income
255.37124.99277.82307.72322.36283.37
Net Income to Common
255.37124.99277.82307.72322.36283.37
Net Income Growth
61.27%-55.01%-9.71%-4.54%13.76%19.69%
Shares Outstanding (Basic)
379379386385347346
Shares Outstanding (Diluted)
379379386385347346
Shares Change (YoY)
-1.27%-1.84%0.32%10.97%0.30%-0.75%
EPS (Basic)
0.670.330.720.800.930.82
EPS (Diluted)
0.670.330.720.800.930.82
EPS Growth
63.34%-54.17%-10.00%-13.98%13.41%20.59%
Free Cash Flow
124.5-51.07478.4716.1-34.62236.68
Free Cash Flow Per Share
0.33-0.141.240.04-0.100.69
Dividend Per Share
0.2590.1320.3620.3130.130-
Dividend Growth
-41.80%-63.54%15.65%140.77%--
Gross Margin
63.86%64.09%70.76%74.91%76.17%72.58%
Operating Margin
24.98%11.41%21.62%23.41%31.08%34.12%
Profit Margin
24.24%15.51%22.99%25.61%29.09%30.22%
Free Cash Flow Margin
11.82%-6.34%39.59%1.34%-3.12%25.24%
EBITDA
301.98128.37294.55309.48360.99334.87
EBITDA Margin
28.66%15.93%24.37%25.75%32.58%35.71%
D&A For EBITDA
38.7836.4133.2528.1316.5514.95
EBIT
263.291.96261.3281.35344.44319.92
EBIT Margin
24.98%11.41%21.62%23.41%31.08%34.12%
Effective Tax Rate
7.92%5.27%9.18%8.66%12.25%14.09%
Revenue as Reported
1,054805.861,2091,2021,108937.69
Source: S&P Global Market Intelligence. Standard template. Financial Sources.